Neogenomics Stock

Neogenomics P/B

The P/B (Price-to-Book Ratio) of Neogenomics (NEO) as of Jul 24, 2026 is 1.76. In the previous year, P/B (Price-to-Book Ratio) was 1.63 — a change of 7.86% (higher).

P/B

1.76

YoY

7.86%

Last updated:

P/B (Price-to-Book Ratio) of Neogenomics is 2026 1.76 . P/B (Price-to-Book Ratio) of Neogenomics was 2025 1.63 . It decreases by 7.86% higher compared to the previous year.
Access this data via the Eulerpool API

Neogenomics Stock analysis

What does Neogenomics do? Neogenomics Inc. is a leading company in the field of personalized medicine, based in Fort Myers, Florida. It offers integrated diagnostics and pharmaceutical services for oncology and gene therapy, with a focus on providing accurate diagnosis for cancer patients. Neogenomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogenomics stock

P/B (Price-to-Book Ratio) of Neogenomics is 1.76 in 2026.

Access this data via the Eulerpool API

Valuation — Neogenomics

All Key Metrics — Neogenomics